Market Cap

Vectura Group plc Market Capitalization:

£1.00 Billion

GBP as of Oct. 1, 2021

US$1.36 Billion

business Vectura Group plc Company Profile

Vectura Group plc Main Stock Listing

LSE: VEC

Market Capitalization History of Vectura Group plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Drug Manufacturers—General
Company Market Cap (USD)
Lilly $808.65 B
Johnson & Johnson $350.63 B
Merck $318.75 B
AbbVie $295.34 B
AstraZeneca $236.45 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $808.65 B
Novo Nordisk $622.07 B
UnitedHealth Group $450.89 B
Johnson & Johnson $350.63 B
Merck $318.75 B

Yearly evolution of Vectura Group plc market cap

Date Market Cap YoY Change
Jan. 1, 2021 £716.2 M 24.79%
Jan. 1, 2020 £573.9 M 16.29%
Jan. 1, 2019 £493.5 M -23.64%
Jan. 1, 2018 £646.3 M -25.33%
Jan. 1, 2017 £865.5 M -22.39%
Jan. 1, 2016 £1.12 B 10.64%
Jan. 1, 2015 £1.01 B -5.30%
Jan. 1, 2014 £1.06 B 72.31%
Jan. 1, 2013 £617.7 M 71.49%
Jan. 1, 2012 £360.2 M -28.13%
Jan. 1, 2011 £501.2 M 18.05%
Jan. 1, 2010 £424.6 M 9.92%
Jan. 1, 2009 £386.3 M 29.90%
Jan. 1, 2008 £297.4 M -44.25%
Jan. 1, 2007 £533.4 M -5.43%
Jan. 1, 2006 £564.1 M 44.88%
Jan. 1, 2005 £389.3 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Vectura Group plc Categories

United Kingdom languages Healthcare languages Drug Manufacturers—General
United Kingdom Healthcare United Kingdom Drug Manufacturers—General

Stocks & Indices

Vectura Group plc has the following listings and related stock indices.


Stock: LSE: VEC

Stock: FSX: V4TA

Stock: OTC: VEGPF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.